Abstract
Inhaled and intranasal corticosteroids are widely used as effective, first-line treatments for asthma and allergic rhinitis. Despite a good safety profile of these formulations, there is increasing concern about their propensity to produce systemic adverse effects. Suppression of the hypothalamic-pituitary-adrenal axis is one of the most important potential complications. This article reviews the effects of inhaled and intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis function in adults and children.
MeSH terms
-
Administration, Inhalation
-
Administration, Intranasal
-
Adult
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / pharmacokinetics
-
Asthma / drug therapy
-
Child
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / adverse effects*
-
Glucocorticoids / pharmacokinetics
-
Humans
-
Hypothalamo-Hypophyseal System / drug effects*
-
Nasal Polyps / drug therapy
-
Nebulizers and Vaporizers
-
Pituitary-Adrenal System / drug effects*
-
Rhinitis / drug therapy
Substances
-
Anti-Inflammatory Agents
-
Glucocorticoids